Abstract
BackgroundAnti-nuclear antibodies (ANA) represent serological hallmarks of systemic rheumatic diseases (SARD), and have been traditionally identified by indirect immunofluorescence (IIF) on HEp-2 cells, followed by antigen-specific confirmation assays. Several new...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have